Summary
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is the development of an automated system that dramatically improves the preparation of blood-based cancer tests, known as liquid biopsies. Liquid biopsy has the potential to detect cancer earlier and for therapeutic monitoring and minimal residual disease testing by analyzing circulating tumor DNA shed by tumors into the bloodstream. However, the current preparation process is lengthy, expensive, and requires highly-skilled labor, limiting its widespread use. This project seeks to overcom
